Simmons Bank’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $452K | Hold |
2,675
| – | – | 0.03% | 261 |
|
|
2025
Q4 | $451K | Hold |
2,675
| – | – | 0.03% | 256 |
|
|
2025
Q3 | $386K | Hold |
2,675
| – | – | 0.03% | 269 |
|
|
2025
Q2 | $338K | Hold |
2,675
| – | – | 0.02% | 275 |
|
|
2025
Q1 | $342K | Hold |
2,675
| – | – | 0.03% | 275 |
|
|
2024
Q4 | $354K | Hold |
2,675
| – | – | 0.03% | 274 |
|
|
2024
Q3 | $389K | Hold |
2,675
| – | – | 0.03% | 262 |
|
|
2024
Q2 | $367K | Hold |
2,675
| – | – | 0.03% | 265 |
|
|
2024
Q1 | $367K | Hold |
2,675
| – | – | 0.03% | 276 |
|
|
2023
Q4 | $363K | Hold |
2,675
| – | – | 0.03% | 273 |
|
|
2023
Q3 | $327K | Hold |
2,675
| – | – | 0.03% | 273 |
|
|
2023
Q2 | $340K | Hold |
2,675
| – | – | 0.03% | 273 |
|
|
2023
Q1 | $346K | Hold |
2,675
| – | – | 0.03% | 271 |
|
|
2022
Q4 | $351K | Hold |
2,675
| – | – | 0.03% | 272 |
|
|
2022
Q3 | $313K | Sell |
2,675
-100
| -4% | -$12.4K | 0.03% | 285 |
|
|
2022
Q2 | $326K | Sell |
2,775
-50
| -2% | -$5.93K | 0.03% | 290 |
|
|
2022
Q1 | $368K | Hold |
2,825
| – | – | 0.03% | 292 |
|
|
2021
Q4 | $431K | Hold |
2,825
| – | – | 0.03% | 299 |
|
|
2021
Q3 | $457K | Hold |
2,825
| – | – | 0.03% | 288 |
|
|
2021
Q2 | $462K | Hold |
2,825
| – | – | 0.03% | 286 |
|
|
2021
Q1 | $425K | Hold |
2,825
| – | – | 0.03% | 283 |
|
|
2020
Q4 | $428K | Hold |
2,825
| – | – | 0.03% | 278 |
|
|
2020
Q3 | $383K | Hold |
2,825
| – | – | 0.03% | 275 |
|
|
2020
Q2 | $386K | Sell |
2,825
-253
| -8% | -$32.3K | 0.03% | 276 |
|
|
2020
Q1 | $332K | Sell |
3,078
-137
| -4% | -$15.8K | 0.03% | 278 |
|
|
2019
Q4 | $387K | Sell |
3,215
-1,880
| -37% | -$210K | 0.03% | 279 |
|
|
2019
Q3 | $507K | Sell |
5,095
-19,196
| -79% | -$2.01M | 0.05% | 256 |
|
|
2019
Q2 | $2.65M | Buy |
24,291
+1,527
| +7% | +$162K | 0.26% | 88 |
|
|
2019
Q1 | $2.54M | Buy |
22,764
+778
| +4% | +$85.3K | 0.25% | 92 |
|
|
2018
Q4 | $2.12M | Buy |
21,986
+471
| +2% | +$50K | 0.24% | 92 |
|
|
2018
Q3 | $2.62M | Sell |
21,515
-567
| -3% | -$66.8K | 0.26% | 85 |
|
|
2018
Q2 | $2.42M | Sell |
22,082
-582
| -3% | -$62.2K | 0.22% | 93 |
|
|
2018
Q1 | $2.42M | Buy |
22,664
+515
| +2% | +$57.1K | 0.22% | 83 |
|
|
2017
Q4 | $2.37M | Sell |
22,149
-270
| -1% | -$28.9K | 0.24% | 91 |
|
|
2017
Q3 | $2.49M | Sell |
22,419
-132
| -0.6% | -$14.1K | 0.26% | 78 |
|
|
2017
Q2 | $2.33M | Sell |
22,551
-81
| -0.4% | -$7.98K | 0.26% | 80 |
|
|
2017
Q1 | $2.21M | Buy |
+22,632
| New | +$2.17M | 0.24% | 80 |
|
Other funds holding IBB
CB
Simmons Bank's IBB Position: Q1 2026 in Review
Simmons Bank held its iShares Biotechnology ETF (IBB) position steady in Q1 2026 at 2,675 shares worth $452K. The position accounts for 0.03% of the portfolio, ranked #261.
Simmons Bank first reported a position in IBB in Q1 2017 and has held it in 37 quarters since. The position peaked at $2.65M in Q2 2019. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.
- Simmons Bank held 2,675 shares of iShares Biotechnology ETF worth $452K as of Q1 2026.
- Simmons Bank left its iShares Biotechnology ETF share count unchanged in Q1 2026.
- iShares Biotechnology ETF made up 0.03% of Simmons Bank's portfolio in Q1 2026, its #261 holding.
- Simmons Bank first reported a position in iShares Biotechnology ETF in Q1 2017 and has held it in 37 quarters since.
- Simmons Bank's iShares Biotechnology ETF position peaked at $2.65M in Q2 2019.
- 917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.
Based on Simmons Bank's 13F filing for Q1 2026, filed 23 Apr 2026.